BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19099624)

  • 21. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W; Zhang MH; Yu Y; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production.
    Corazza F; Beguin Y; Bergmann P; André M; Ferster A; Devalck C; Fondu P; Buyse M; Sariban E
    Blood; 1998 Sep; 92(5):1793-8. PubMed ID: 9716610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic tracer kinetics analysis of changes in erythropoietin receptor population in phlebotomy-induced anemia and bone marrow ablation.
    Veng-Pedersen P; Chapel S; Al-Huniti NH; Schmidt RL; Sedars EM; Hohl RJ; Widness JA
    Biopharm Drug Dispos; 2004 May; 25(4):149-56. PubMed ID: 15108217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin receptor expression in normal and neoplastic choroid plexus.
    Beschorner R; Psaras T; Meyermann R; Bremer J; Schmidt T; Mittelbronn M; Schittenhelm J
    Clin Neuropathol; 2011; 30(1):33-40. PubMed ID: 21176716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies to erythropoietin receptor in patients with immune-mediated diseases: relationship to anaemia with erythroid hypoplasia.
    Hara A; Furuichi K; Higuchi M; Iwata Y; Sakai N; Kaneko S; Wada T
    Br J Haematol; 2013 Jan; 160(2):244-50. PubMed ID: 23151030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
    Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
    Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Proliferative signal transmission mediated by EpoR in leukemic cell lines].
    Fan H; Kanji S; Zhai M
    Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):294-7. PubMed ID: 11876995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis.
    Takashina N; Kondo H; Kashiwazaki S
    J Rheumatol; 1990 Jul; 17(7):885-7. PubMed ID: 2213753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of thrombopoietin and its receptor C-mpl in acute leukemia].
    Guo Y; Bian S; Luo M
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):120-3. PubMed ID: 11601235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preliminary study of autoantigens on the membrane of erythropoietic cells of the patients with BMMNC-Coomb's test(+) hemocytopenia].
    Fu R; Liu H; Wang J; Li LJ; Wang HL; Wang YH; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(38):2689-93. PubMed ID: 23290107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Erythropoietin levels in patients with multiple sclerosis complicated with anemia].
    Wang DH; Li YM; Wu TH; Li J; Su DH; Xiang NW; Xiang Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):84-7. PubMed ID: 23469797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin receptor is expressed in meningiomas and lower levels are associated with tumour recurrence.
    Küster O; Simon P; Mittelbronn M; Tabatabai G; Hermann C; Strik H; Dietz K; Roser F; Meyermann R; Schittenhelm J
    Neuropathol Appl Neurobiol; 2009 Dec; 35(6):555-65. PubMed ID: 19298633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of expression and function of erythropoietin receptors in the kidney.
    Elliott S; Busse L; Swift S; McCaffery I; Rossi J; Kassner P; Begley CG
    Nephrol Dial Transplant; 2012 Jul; 27(7):2733-45. PubMed ID: 22167585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of functional erythropoietin receptors of cancer cell lines.
    Laugsch M; Metzen E; Svensson T; Depping R; Jelkmann W
    Int J Cancer; 2008 Mar; 122(5):1005-11. PubMed ID: 17990315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of erythropoietin and its receptor in the brain of newborn rats suffering from fetal distress].
    Zhang ZM; Tian ZF; Li YH; Zhao S
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):912-6. PubMed ID: 22099204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin improves insulin resistance via the regulation of its receptor-mediated signaling pathways in 3T3L1 adipocytes.
    Pan Y; Shu JL; Gu HF; Zhou DC; Liu XL; Qiao QY; Fu SK; Gao FH; Jin HM
    Mol Cell Endocrinol; 2013 Mar; 367(1-2):116-23. PubMed ID: 23313788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expressive changes of CD4(+)T cell subset transcription factors in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia and their clinical significances].
    Feng XM; Xu HZ; Zhang JY; Yin DM; Liu MM; Sui XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1038-42. PubMed ID: 25130824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin C affects the expression of hepcidin and erythropoietin receptor in HepG2 cells.
    Chiu PF; Ko SY; Chang CC
    J Ren Nutr; 2012 May; 22(3):373-6. PubMed ID: 22227182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Red blood cell precursor mass as an independent determinant of serum erythropoietin level.
    Cazzola M; Guarnone R; Cerani P; Centenara E; Rovati A; Beguin Y
    Blood; 1998 Mar; 91(6):2139-45. PubMed ID: 9490701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.